Q301--662-20-1-146-0003 Anatomic Pathology Decipher Tests: Decipher Prostate Cancer Classifier Biopsy & Decipher Prostate Cancer Classifier Post-Op Test

The Department of Veterans Affairs, Network Contracting Office 21, issued pre-solicitation notice 36C26120Q0010 regarding its intent to award a sole-source, firm-fixed-price contract to Decipher Corp. The procurement covers the Decipher Prostate Cancer Test and its results, specifically the Decipher Prostate Cancer Classifier Biopsy and the Decipher Prostate Cancer Classifier Post-Op Test. This proprietary genomic testing assesses tumor aggressiveness and predicts the probability of metastasis following surgery to assist San Francisco VA Medical Center physicians in making clinical diagnoses and treatment decisions for Veteran patients.

The testing provides data on clinically useful endpoints, including high-grade disease likelihood, 5-year metastasis, and 10-year prostate cancer-specific mortality. This requirement is classified under NAICS 621511 Medical Laboratories and PSC Q301 MEDICAL- LABORATORY TESTING. As a sole-source action, a Justification and Approval will be posted in accordance with FAR 13.501(a)(1)(iii).

The anticipated period of performance runs from April 1, 2020, through March 31, 2023. Contractual performance takes place in the United States under the administration of the Network Contracting Office 21. Licia Haynie is the designated point of contact for this notice, which was published on March 13, 2020.